Abstract
Progress in prevention and treatment of Alzheimer’s disease (AD) and dementia is hampered by the restricted understanding of the biological and environmental causes underlying pathophysiology. It is widely accepted that certain genetic factors are associated with AD and a number of lifestyle and other environmental characteristics have also been linked to dementia risk. However, interactions between genes and the environment are not yet well understood, and coordinated global action is required to utilize existing cohorts and other resources effectively and efficiently to identify new avenues for dementia prevention. This chapter provides a brief summary of current research on risk and protective factors and opportunities and challenges in relation to population-based approaches are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hutter CM, Mechanic LE, Chatterjee N et al (2013) Gene-environment interactions in cancer epidemiology: a National Cancer Institute Think Tank report. Genet Epidemiol 37(7):643–657. https://doi.org/10.1002/gepi.21756
The Lancet Neurology (2014) G8 dementia summit: a chance for united action. Lancet Neurol 13(1):1. https://doi.org/10.1016/S1474-4422(13)70275-8
Prince M, Wimo A, Guerchet M et al. (2015) World Alzheimer Report 2015—The Global Impact of Dementia: an analysis of prevalence, incidence, cost and trend. London, UK: Alzheimer’s Disease International
Scheltens P, Blennow K, Breteler MM et al (2016) Alzheimer’s disease. Lancet 388(10043):505–517. https://doi.org/10.1016/S0140-6736(15)01124-1
Lambert JC, Ibrahim-Verbaas CA, Harold D et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45(12):1452–1458. https://doi.org/10.1038/ng.2802
Terracciano A, Sutin AR, An Y et al (2014) Personality and risk of Alzheimer’s disease: new data and meta-analysis. Alzheimers Dement 10(2):179–186. https://doi.org/10.1016/j.jalz.2013.03.002
JPND. Longitudinal cohort studies in neurodegeneration research. Report of the JPND Action Group (2013)
Elbaz A, Dufouil C, Alperovitch A (2007) Interaction between genes and environment in neurodegenerative diseases. C R Biol 330(4):318–328. https://doi.org/10.1016/j.crvi.2007.02.018
Barberger-Gateau P, Lambert JC, Feart C et al (2013) From genetics to dietetics: the contribution of epidemiology to understanding Alzheimer’s disease. J Alzheimers Dis 33(Suppl 1):S457–S463. https://doi.org/10.3233/JAD-2012-129019
Ferrari C, WL X, Wang HX et al (2013) How can elderly apolipoprotein E epsilon4 carriers remain free from dementia? Neurobiol Aging 34(1):13–21. https://doi.org/10.1016/j.neurobiolaging.2012.03.003
Yang Z, Slavin MJ, Sachdev PS (2013) Dementia in the oldest old. Nat Rev Neurol 9(7):382–393. https://doi.org/10.1038/nrneurol.2013.105
Barberger-Gateau P, Samieri C, Feart C et al (2011) Dietary omega 3 polyunsaturated fatty acids and Alzheimer’s disease: interaction with apolipoprotein E genotype. Curr Alzheimer Res 8(5):479–491
Hofman A, Ott A, Breteler MM et al (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet 349(9046):151–154. https://doi.org/10.1016/S0140-6736(96)09328-2
Rovio S, Kareholt I, Helkala EL et al (2005) Leisure-time physical activity at midlife and the risk of dementia and Alzheimer’s disease. Lancet Neurol 4(11):705–711. https://doi.org/10.1016/S1474-4422(05)70198-8
Cunnane SC, Plourde M, Pifferi F et al (2009) Fish, docosahexaenoic acid and Alzheimer’s disease. Prog Lipid Res 48(5):239–256. https://doi.org/10.1016/j.plipres.2009.04.001
Clarke RJ, Bennett DA (2008) B vitamins for prevention of cognitive decline: insufficient evidence to justify treatment. JAMA 300(15):1819–1821. https://doi.org/10.1001/jama.300.15.1819
Annweiler C, Montero-Odasso M, Llewellyn DJ et al (2013) Meta-analysis of memory and executive dysfunctions in relation to vitamin D. Journal Alzheimers Dis 37(1):147–171. https://doi.org/10.3233/JAD-130452
Mapstone M, Cheema AK, Fiandaca MS et al (2014) Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 20(4):415–418. https://doi.org/10.1038/nm.3466
Feart C, Samieri C, Alles B et al (2013) Potential benefits of adherence to the Mediterranean diet on cognitive health. Proc Nutr Soc 72(1):140–152. https://doi.org/10.1017/S0029665112002959
Martinez-Lapiscina EH, Clavero P, Toledo E et al (2013) Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial. J Nutr Health Aging 17(6):544–552. https://doi.org/10.1007/s12603-013-0027-6
Scheltens P, Twisk JW, Blesa R et al (2012) Efficacy of Souvenaid in mild Alzheimer’s disease: results from a randomized, controlled trial. J Alzheimers Dis 31(1):225–236. https://doi.org/10.3233/JAD-2012-121189
Barberger-Gateau P, Feart C, Samieri C et al (2013) Dietary patterns and dementia. In: Yaffe K (ed) Chronic medical disease and cognitive aging: toward a healthy body and brain. Oxford University Press, New York, pp 197–224
Quinn JF, Raman R, Thomas RG et al (2010) Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 304(17):1903–1911. https://doi.org/10.1001/jama.2010.1510
Morris MC, Evans DA, Bienias JL et al (2002) Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 287(24):3230–3237
Luchsinger JA, Tang MX, Shea S et al (2002) Caloric intake and the risk of Alzheimer disease. Arch Neurol 59(8):1258–1263
Kharrazi H, Vaisi-Raygani A, Rahimi Z et al (2008) Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease. Clin Biochem 41(12):932–936. https://doi.org/10.1016/j.clinbiochem.2008.05.001
Lambert JC, Heath S, Even G et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41(10):1094–1099. https://doi.org/10.1038/ng.439
Sleegers K, Lambert JC, Bertram L et al (2010) The pursuit of susceptibility genes for Alzheimer’s disease: progress and prospects. Trends Genet 26(2):84–93. https://doi.org/10.1016/j.tig.2009.12.004
Martinez-Lapiscina EH, Galbete C, Corella D et al (2014) Genotype patterns at CLU, CR1, PICALM and APOE, cognition and Mediterranean diet: the PREDIMED-NAVARRA trial. Genes Nutr 9(3):393. https://doi.org/10.1007/s12263-014-0393-7
Harslof LB, Larsen LH, Ritz C et al (2013) FADS genotype and diet are important determinants of DHA status: a cross-sectional study in Danish infants. Am J Clin Nutr 97(6):1403–1410. https://doi.org/10.3945/ajcn.113.058685
Lemaitre RN, Tanaka T, Tang W et al (2011) Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet 7(7):e1002193. https://doi.org/10.1371/journal.pgen.1002193
Ferrucci L, Perry JR, Matteini A et al (2009) Common variation in the beta-carotene 15,15′-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am J Hum Genet 84(2):123–133. https://doi.org/10.1016/j.ajhg.2008.12.019
Kathiresan S, Willer CJ, Peloso GM et al (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41(1):56–65. https://doi.org/10.1038/ng.291
van Meurs JB, Pare G, Schwartz SM et al (2013) Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. Am J Clin Nutr 98(3):668–676. https://doi.org/10.3945/ajcn.112.044545
Scarmeas N, Luchsinger JA, Schupf N et al (2009) Physical activity, diet, and risk of Alzheimer disease. JAMA 302(6):627–637. https://doi.org/10.1001/jama.2009.1144
Tolppanen AM, Solomon A, Kulmala J et al (2015) Leisure-time physical activity from mid- to late life, body mass index, and risk of dementia. Alzheimers Dement 11(4):434–443.e6. https://doi.org/10.1016/j.jalz.2014.01.008
Wilson RS, Mendes De Leon CF, Barnes LL et al (2002) Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 287(6):742–748
Stern Y, Gurland B, Tatemichi TK et al (1994) Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 271(13):1004–1010
Paillard-Borg S, Fratiglioni L, Xu W et al (2012) An active lifestyle postpones dementia onset by more than one year in very old adults. J Alzheimers Dis 31(4):835–842. https://doi.org/10.3233/JAD-2012-120724
Liu Y, Julkunen V, Paajanen T et al (2012) Education increases reserve against Alzheimer’s disease—evidence from structural MRI analysis. Neuroradiology 54(9):929–938. https://doi.org/10.1007/s00234-012-1005-0
Finkel D, Andel R, Gatz M et al (2009) The role of occupational complexity in trajectories of cognitive aging before and after retirement. Psychol Aging 24(3):563–573. https://doi.org/10.1037/a0015511
Karp A, Andel R, Parker MG et al (2009) Mentally stimulating activities at work during midlife and dementia risk after age 75: follow-up study from the Kungsholmen Project. Am J Geriatr Psychiatry 17(3):227–236. https://doi.org/10.1097/JGP.0b013e318190b691
Stern Y (2012) Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol 11(11):1006–1012. https://doi.org/10.1016/S1474-4422(12)70191-6
Cotman CW, Berchtold NC (2002) Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 25(6):295–301
Rovio S, Spulber G, Nieminen LJ et al (2010) The effect of midlife physical activity on structural brain changes in the elderly. Neurobiol Aging 31(11):1927–1936. https://doi.org/10.1016/j.neurobiolaging.2008.10.007
Komulainen P, Pedersen M, Hanninen T et al (2008) BDNF is a novel marker of cognitive function in ageing women: the DR’s EXTRA Study. Neurobiol Learn Mem 90(4):596–603. https://doi.org/10.1016/j.nlm.2008.07.014
Wang HX, Gustafson DR, Kivipelto M et al (2012) Education halves the risk of dementia due to apolipoprotein epsilon4 allele: a collaborative study from the Swedish brain power initiative. Neurobiol Aging 33(5):1007.e1–1007.e7. https://doi.org/10.1016/j.neurobiolaging.2011.10.003
Wirth M, Villeneuve S, La Joie R et al (2014) Gene-environment interactions: lifetime cognitive activity, APOE genotype, and beta-amyloid burden. J Neurosci 34(25):8612–8617. https://doi.org/10.1523/JNEUROSCI.4612-13.2014
Maioli S, Puerta E, Merino-Serrais P et al (2012) Combination of apolipoprotein E4 and high carbohydrate diet reduces hippocampal BDNF and arc levels and impairs memory in young mice. J Alzheimers Dis 32(2):341–355. https://doi.org/10.3233/JAD-2012-120697
Ferencz B, Laukka EJ, Welmer AK et al (2014) The benefits of staying active in old age: physical activity counteracts the negative influence of PICALM, BIN1, and CLU risk alleles on episodic memory functioning. Psychol Aging 29(2):440–449. https://doi.org/10.1037/a0035465
Cohen RA, Grieve S, Hoth KF et al (2006) Early life stress and morphometry of the adult anterior cingulate cortex and caudate nuclei. Biol Psychiatry 59(10):975–982. https://doi.org/10.1016/j.biopsych.2005.12.016
Wolkowitz OM, Epel ES, Reus VI et al (2010) Depression gets old fast: do stress and depression accelerate cell aging? Depress Anxiety 27(4):327–338. https://doi.org/10.1002/da.20686
Savva GM, Wharton SB, Ince PG et al (2009) Age, neuropathology, and dementia. N Engl J Med 360(22):2302–2309. https://doi.org/10.1056/NEJMoa0806142
Seidler A, Nienhaus A, Bernhardt T et al (2004) Psychosocial work factors and dementia. Occup Environ Med 61(12):962–971. https://doi.org/10.1136/oem.2003.012153
Fratiglioni L, Qiu C (2011) Prevention of cognitive decline in ageing: dementia as the target, delayed onset as the goal. Lancet Neurol 10(9):778–779. https://doi.org/10.1016/S1474-4422(11)70145-4
McEwen BS, Morrison JH (2013) The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course. Neuron 79(1):16–29. https://doi.org/10.1016/j.neuron.2013.06.028
Wang HX, Karp A, Herlitz A et al (2009) Personality and lifestyle in relation to dementia incidence. Neurology 72(3):253–259. https://doi.org/10.1212/01.wnl.0000339485.39246.87
Hahn EA, Wang HX, Andel R et al (2014) A change in sleep pattern may predict Alzheimer disease. Am J Geriatr Psychiatry 22(11):1262–1271. https://doi.org/10.1016/j.jagp.2013.04.015
Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 10(9):819–828. https://doi.org/10.1016/S1474-4422(11)70072-2
Skoog I, Lernfelt B, Landahl S et al (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347(9009):1141–1145
Hanon O, Haulon S, Lenoir H et al (2005) Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke 36(10):2193–2197. https://doi.org/10.1161/01.STR.0000181771.82518.1c
Ott A, Stolk RP, van Harskamp F et al (1999) Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53(9):1937–1942
Anstey KJ, von Sanden C, Salim A et al (2007) Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 166(4):367–378. https://doi.org/10.1093/aje/kwm116
Anstey KJ, Lipnicki DM, Low LF (2008) Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 16(5):343–354. https://doi.org/10.1097/JGP.0b013e31816b72d4
de la Torre JC (2006) How do heart disease and stroke become risk factors for Alzheimer’s disease? Neurol Res 28(6):637–644. https://doi.org/10.1179/016164106X130362
Newman AB, Fitzpatrick AL, Lopez O et al (2005) Dementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 53(7):1101–1107. https://doi.org/10.1111/j.1532-5415.2005.53360.x
van Oijen M, de Jong FJ, Witteman JC et al (2007) Atherosclerosis and risk for dementia. Ann Neurol 61(5):403–410. https://doi.org/10.1002/ana.21073
Wendell CR, Waldstein SR, Ferrucci L et al (2012) Carotid atherosclerosis and prospective risk of dementia. Stroke 43(12):3319–3324. https://doi.org/10.1161/STROKEAHA.112.672527
Radanovic M, Pereira FR, Stella F et al (2013) White matter abnormalities associated with Alzheimer’s disease and mild cognitive impairment: a critical review of MRI studies. Expert Rev Neurother 13(5):483–493. https://doi.org/10.1586/ern.13.45
de Bruijn RF, Akoudad S, Cremers LG et al (2014) Determinants, MRI correlates, and prognosis of mild cognitive impairment: the Rotterdam study. J Alzheimers Dis 42(Suppl 3):S239–S249. https://doi.org/10.3233/JAD-132558
Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365(9468):1415–1428. https://doi.org/10.1016/S0140-6736(05)66378-7
Skoog I, Kalaria RN, Breteler MM (1999) Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord 13(Suppl 3):S106–S114
de Leeuw FE, Richard F, de Groot JC et al (2004) Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke 35(5):1057–1060. https://doi.org/10.1161/01.STR.0000125859.71051.83
Hollingworth P, Harold D, Sims R et al (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet 43(5):429–435. https://doi.org/10.1038/ng.803
Hovingh GK, Van Wijland MJ, Brownlie A et al (2003) The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia. J Lipid Res 44(6):1251–1255. https://doi.org/10.1194/jlr.M300080-JLR200
Imhof A, Kovari E, von Gunten A et al (2007) Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm? J Neurol Sci 257(1-2):72–79. https://doi.org/10.1016/j.jns.2007.01.025
Serrano-Pozo A, Frosch MP, Masliah E et al (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189. https://doi.org/10.1101/cshperspect.a006189
Qiu C, Kivipelto M, von Strauss E (2009) Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11(2):111–128
Matthews FE, Arthur A, Barnes LE et al (2013) A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet 382(9902):1405–1412. https://doi.org/10.1016/S0140-6736(13)61570-6
Qiu C, von Strauss E, Backman L et al (2013) Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology 80(20):1888–1894. https://doi.org/10.1212/WNL.0b013e318292a2f9
Acknowledgments
The author would like to thank the following individuals for their valuable contribution to the chapter: Profs Lefkos Middleton (Imperial College London, UK); Miia Kivipelto and Laura Fratiglioni (Karolinska Institutet Stockholm, Sweden); M. Arfan Ikram (Erasmus University Medical Center Rotterdam, The Netherlands); and Pascale Barberger-Gateau and Cécilia Samieri (Inserm U1219 and Bordeaux University, France).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Perneczky, R. (2018). Population-Based Approaches to Alzheimer’s Disease Prevention. In: Perneczky, R. (eds) Biomarkers for Alzheimer’s Disease Drug Development. Methods in Molecular Biology, vol 1750. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7704-8_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7704-8_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7703-1
Online ISBN: 978-1-4939-7704-8
eBook Packages: Springer Protocols